Evidence map›Paper›PMID 42872673›Full record

ArticlePsycho-oncology2026

Financial Toxicity and Follow-Up Quality of Life Among Breast Cancer Survivors in the BOLD Cohort.

Ivan H C Wu, Rachel I Vogel, Patricia I Jewett, Anne H Blaes

Abstract read
In one paragraph

Article in Psycho-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ivan H C WuDivision of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0002-0118-0555
Rachel I VogelMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0003-0149-8464
Patricia I JewettDivision of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0001-5313-0106
Anne H BlaesMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0002-5433-4810

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
Social determinants of sleep and obesity: Disparities in African AmericansR00MD015296 · NIMHD · UNIVERSITY OF MINNESOTA · PI WU, IVAN H · 2023 to 2025
$730k
Health's National Center for Advancing Translational Sciences UL1TR002494NCATS NIH HHS UL1 TR002494NCI NIH HHS P30 CA077598NCI NIH HHS P30 CA77598NIMHD NIH HHS R00 MD015296NIMHD NIH HHS R00MD015296
6 · The paper itself

Abstract

backgroundFinancial toxicity is prevalent in cancer survivorship and has been associated with poorer health-related quality of life (HRQOL), yet longitudinal evidence remains limited. We examined associations between financial toxicity and HRQOL at baseline and 4-month follow-up among breast cancer survivors in the BOLD cohort.

methodsData were drawn from self-report questionnaires completed by 182 breast cancer survivors at baseline, of whom 146 completed 4-month follow-up surveys. Financial toxicity was assessed at baseline using the Comprehensive Score for Financial Toxicity (COST). HRQOL outcomes were assessed at baseline and approximately 4 months later using the Functional Assessment of Cancer Therapy-General (FACT-G) subscales and total score, and a single-item measure of sleep disturbance. Multivariable linear regression models estimated adjusted cross-sectional associations and longitudinal associations between baseline financial toxicity and follow-up outcomes, adjusting for baseline levels of the corresponding outcome. Longitudinal measurement invariance of the COST was evaluated.

resultsGreater baseline financial toxicity was associated with lower baseline physical, social/family, emotional, and functional well-being, lower FACT-G total score, and greater sleep disturbance. In longitudinal models, higher baseline financial toxicity was associated with lower follow-up physical, social/family, emotional, and functional well-being and lower FACT-G total score after adjustment for demographic and clinical covariates and the corresponding baseline outcome. Baseline financial toxicity was not associated with follow-up sleep disturbance.

conclusionsFinancial toxicity was associated with poorer HRQOL at baseline and with lower physical, social/family, emotional, functional, and overall HRQOL at follow-up. These findings support greater attention to financial toxicity in survivorship care.

Indexed as

Breast NeoplasmsCancer SurvivorsCost of IllnessFinancial StressQuality of LifeAdultAgedCross-Sectional StudiesFemaleFollow-Up StudiesHumansLongitudinal StudiesMiddle AgedSleep Wake DisordersSurveys and Questionnairesbreast cancer survivorshipFACT‐Gfinancial toxicitypatient‐reported outcomesquality of life

Identifiers

PMID42872673
PMCPMC13663844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.